HC006

· HC Biopharma Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HC006, covering 2025-05-06 to 2025-07-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of HC006 in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumors [Phase 1]